Abstract
The elevation of chylomicrons and chylomicron remnants in plasma would lead to hyperlipidemia and other complications. Apo B‐48, which is translated and produced in the adult intestine from the same gene as Apo B‐100, is considered to be an essential component of chylomicrons and chylomicron remnants. Using a peptide representing human Apo B‐48 C‐terminal sequence as immunogen, we established a monoclonal antibody, B48‐151, against human Apo B‐48. The specific reactivity for Apo B‐48 of this monoclonal antibody was confirmed using Western blot analysis of human plasma in fractions isolated as chylomicron and VLDL. Then, we developed a simple sandwich ELISA method for the detection of human Apo B‐48 in serum by combining B48‐151 as capturing antibody and HRP‐conjugated‐polyclonal antibodies for Apo B as signaling antibody. The established sandwich ELISA constitutes a simple method to monitor Apo B‐48 level in chylomicrons and chylomicron remnants in human serum. J. Clin. Lab. Anal. 12:289–292, 1998. © 1998 Wiley‐Liss, Inc.
Keywords: apolipoprotein B‐48, chylomicron remnant, postprandial lipidemia, Western blot analysis
References
- 1. Hussain MM, Kancha RK, Zhou Z, Luchoomun J, Zu H, and Bakillah A: Chylomicron assembly and catabolism: Role of apolipoproteins and receptors. Biochim Biophys Acta 1300: 151–170, 1996. [DOI] [PubMed] [Google Scholar]
- 2. Chen S‐H, Habib G, Yang C‐Y, et al.: Apolipoprotein B‐48 is the product of a messenger RNA with an organ‐specific in‐frame stop codon. Science 238: 363–366, 1987. [DOI] [PubMed] [Google Scholar]
- 3. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, and Scott J: A novel form of tissue‐specific RNA processing produces apolipoprotein‐B48 in intestine. Cell 50: 831–840, 1987. [DOI] [PubMed] [Google Scholar]
- 4. Redgrave TG: Formation and metabolism of chylomicrons. Int Rev Physiol 28: 103–130, 1983. [PubMed] [Google Scholar]
- 5. Iaina A, Silverberg DS, Wollman Y, et al.: Postprandial intestinal‐derived chylomicron and chylomicron remnants in essential hypertensive patients before and after prolonged captopril therapy. Am J Hypertension 8: 34–39, 1995. [DOI] [PubMed] [Google Scholar]
- 6. Nakajima K, Saito T, Tamura A, et al.: Cholesterol in remnant‐like lipoproteins in human serum using monoclonal anti Apo B‐100 and anti Apo A‐I immunoaffinity mixed gels. Clin Chim Acta 223: 53–71, 1993. [DOI] [PubMed] [Google Scholar]
- 7. Smith D, Proctor SD, and Mamo JCL: A highly sensitive assay for quantitation of apolipoprotein B‐48 using an antibody to human apolipoprotein B and enhanced chemiluminescence. Ann Clin Biochem 34: 185–189, 1997. [DOI] [PubMed] [Google Scholar]
- 8. Peel AS, Zampelas A, Williams CM, and Gould BJ: A novel antiserum specific to Apolipoprotein B‐48: Application in the investigation of postprandial lipidaemia in humans. Clin Sci 85: 521–524, 1993. [DOI] [PubMed] [Google Scholar]
- 9. Yao Z, Blackhart BD, Johnson DF, Taylor SM, Haubold KW, and McCarthy BJ: Elimination of Apolipoprotein B‐48 formation in rat hepatoma cell lines transfected with mutant human Apolipoprotein B cDNA constructs. J Biol Chem 267: 1175–1182, 1992. [PubMed] [Google Scholar]
- 10. Yao Z, Blackhart BD, Linton MF, Taylor SM, Young SG, and McCarthy BJ: Expression of carboxyl‐terminally truncated forms of human Apolipoprotein B in rat hepatoma cells: Evidence that the length of Apolipoprotein B has a major effect on the buoyant density of the secreted lipoproteins. J Biol Chem 266: 3300–3308, 1991. [PubMed] [Google Scholar]
- 11. Havel RJ, Eder HA, and Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353, 1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Yang C‐Y, Chen S‐H, Gianturco SH, et al.: Sequence, structure, receptor‐binding domains and internal repeats of human Apolipoprotein B‐100. Nature 323: 738–742, 1986. [DOI] [PubMed] [Google Scholar]